Press Releases

Press Releases

10.13.20
OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel
10.05.20
OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud
09.30.20
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
09.28.20
OpGen Announces Successful Completion of Study Collaboration with Karolinska Institutet on Bacterial Co-Infections in COVID-19 Pneumonia Patients and Presents Data on Unyvero HPN Panel at ECCVID 2020
09.18.20
OpGen, Inc. Announces Notice of Annual Meeting Venue Change
09.16.20
Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing
09.08.20
OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility Test
09.02.20
Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumonia
08.20.20
OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19
08.12.20
OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update